Amryt Pharma Share Discussion Threads

[pottermagic2310] 02/12/2016 09:37

It's News, unexpected News, possibly good News depending on your perspective and one might think "13.5p to load-up, maybe ?" ????

[icebreaker] 02/12/2016 09:30

Rossannan - episalvan phase 3 study starts Q1 2017. Jam not necessarily that far away. This is when the real interest will start!

[currypasty] 02/12/2016 09:21

IMO, the shareprice has drifted quite badly, with no news and people thinking a highly dilutive placing was on the cards. Hopefully the debt finance will have put a line under that and the directors may actually tell us what progress has been made for the lender to cough up that sort of cash to a highly speculative Company.

[currypasty] 02/12/2016 08:58

I would think that the lender must have been happy that amyt will have the income stream to pay back the interest and capital.. will have done a lot of due diligence

[talkman2] 02/12/2016 08:38

Pathetic market response . I would have expected a couple of pence rise as today's news reduces funding uncertainty going forward and avoids a highly -dilutive placing . There seems to be zero interest in the company.

Would be good to see some Director share -buying to restore some belief and confidence.

[currypasty] 02/12/2016 08:24

yes, better than dilution, and by the time the bullet and capital is due the company should be able to cope.. market not too impressed though, I thought it would hold onto some sort of gain

[icebreaker] 02/12/2016 08:24

Rossannan - agree, much better than dilution. A placing would have been at 10p to make it attractive and would have struggled to raise an equivalent amount.

[currypasty] 02/12/2016 08:11

'highly attractive rate'

13% above base ?

[icebreaker] 02/12/2016 07:58

I take it all back!

[papillon] 01/12/2016 23:47

It's no good moaning on this bb, Icebreaker, if you're unhappy. Like any other small PI you only have 2 courses of action open to you; either you sell up, or you grit your teeth and continue to hold and hope and pray for good news sooner rather than later.

Cathal Friel is not going to take any notice of posts on an advfn bb from a disappointed small PI.

If you follow the ShareProphets site you'll see that many fraudulent companies are listed on AIM. Obviously I don't believe AMYT is such a company, otherwise I wouldn't have invested in FAST in the first place and I would long ago have sold my AMYT shares if I thought it was such a company. It's definitely not fraudulent, but it's definitely not pro-active either if the last 6 months are anything to go by. One can only hope that wheels are turning behind the scenes.

By continuing to hold AMYT I'm gambling as is the case with the majority of AIM shares; it's not investing. If I was an investor in pharma and biotech companies I'd be holding the likes of GSK. By holding AMYT I'm just gambling. The rewards are potentially high, but the risks are even greater. Buying shares in AMYT, like any other AIM biotech is a pure punt; rather like buying a lottery ticket.

[icebreaker] 01/12/2016 13:59

I've made the point a couple of times, but if AP102 and Episalvan are outsourced and the 6 monthly report suggests no increase in revenue from Imlan, what is everyone doing?

Why also do we have a Chief Commercial Officer?

Ali4fish - time is something we do not have. We only have enough funds to keep us going until mid-2017 and unless we can do a deal on one of the above products(licencing or otherwise), we will simply disappear. Appetite for a share placing to raise more funds will only come if we can demonstrate progress with some of the above.

Silence is simply not an option Wiley/Nealon!

[jacksonpollack] 01/12/2016 10:41

Ali4fish. Thanks for that. You're a great help, not.

[ali47fish] 01/12/2016 10:24

all this is past history-with such a board this share could go places- but it might take a long time

[jacksonpollack] 01/12/2016 10:11

Cathal can afford to lose it, he's loaded. And each month he gets a nice cheque. It's a win win for him.

[papillon] 01/12/2016 00:09

You should have sold them, JP, when they relinquished their Tendrara option, or are you just being wise with the benefit of hindsight? I'm sure that Cathal Friel wouldn't have let FAST relinquish the Tendrara option if he had known how successful Tendrara has turned out for SOU. He doesn't strike me as the type to turn down the chance of an exceptionally good profit. That's the trouble; he didn't know for certain Tendrara would turn out the way it has. Nor was anyone certain, even you JP. Why? Because O&G exploration is notoriously uncertain and the chances of failure far outweigh the chances of success. However drug development is also notoriously uncertain and failure is far more likely than commercial success.

Cathal Friel gambled when he let FAST relinquish Tendrara; he obviously got the gamble wrong. No need to tell him that, JP. He knows he took a gamble and got it wrong! It's cost you money, BUT IT'S COST HIM EVEN MORE MONEY because he's a far bigger shareholder than you. Get over it, JP!

[jacksonpollack] 30/11/2016 18:36

OPEC deal will drive oil prices up. Tendrara is a £billion gas strike and Amyt/fastnet HAD them both. Now what have they got? A bod full of overpaid underperforming members and no revenue apart form placings. An share price that has been decimated. You Couldn't make this tripe up.

[papillon] 30/11/2016 18:28

Could be a good time to add? Who can know? I have no idea! I can't predict the future (unfortunately!).

Me? I going to put my AMYT shares in the bottom drawer (metaphorically since they are held in a nominee a/c) and wait for the news to flow (and it will, be it within the next month, or next year). Not even worth speculating until we get news.